PHARMACYTE BIOTECH, INC. Increase (Decrease) in Other Current Liabilities
PHARMACYTE BIOTECH, INC. (PMCB) reported Increase (Decrease) in Other Current Liabilities of $0 for the 9-month period ending 2019-01-31, per its 10-Q filed 2019-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2019-03-14
- 2019-01-31: Increase (Decrease) in Other Current Liabilities 9 month $0.00.
- 2018-01-31: Increase (Decrease) in Other Current Liabilities 9 month $300.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 9 month |
|---|---|
| 2019-01-31 | $0.00 10-Q · filed 2019-03-14 |
| 2018-01-31 | $300.00K 10-Q · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |